UCB SA, the Belgian maker of the allergy drug Zyrtec, agreed to buy Germany's Schwarz Pharma AG for 4.4 billion euros (US$5.6 billion) in cash and stock to gain medicines for Parkinson's disease, epilepsy and bladder control.
Shareholders of Schwarz will get 91.10 euros a share, Schwarz said in an e-mailed statement.
That's 20 percent more than the closing price on Friday. The Schwarz-Schuette family, which owns 60 percent of the drugmaker, backed the offer.
Schwarz is the third European family drugmaker to sell in less than a week as the cost of developing new products swells and older ones face generic competition. UCB will get three new drugs that may garner more than 2 billion euros a year in sales, including a patch for Parkinson's disease.
"Schwarz Pharma and UCB are direct competitors with a focus on diseases of the central nervous system," Alexander Groschke, head of equities research at Landesbank Rheinland-Pfalz, said in a note to clients. "Together they will be a world leader in neurology."
Schwarz, the first company to introduce a generic version of AstraZeneca Plc's ulcer drug Prilosec, is shifting from marketing medicines to developing its own products. Shareholders will get 50 euros a share in cash and 0.8735 UCB shares. Chief executive officer Patrick Schwarz-Schuette will get a seat on the board of the enlarged UCB.
UCB shares fell 1.99 euros, or 4.2 percent, to 45.05 euros at 9.04am in Brussels. Those of Schwarz climbed 11.3 euros, or 15 percent, to 87 euros.
UCB is relying on new medicines such as the epilepsy drug Keppra and Crohn's disease treatment Cimzia to spur growth.
Chief executive officer Roch Doliveux has helped focus the company with the purchase of UK biotechnology company Celltech Group Plc in 2004 and last year's sale of the chemicals unit.
"The management of UCB has already proven, through the acquisition of Celltech and other transactions, that it's in a position to successfully acquire and integrate a complementary business," Doliveux said in yesterday's statement.
The companies expect the transaction to generate annual cost savings of more than 300 million euros within three years.
The new company will have annual sales of more than 3.3 billion euros and a research and development budget of 770 million euros a year. UCB plans to sell new shares to help pay for the takeover.
The announcement comes just days after family holders of Serono SA, Europe's largest biotechnology company, agreed to sell their stake to Merck KGaA, controlled by the descendants of founder Friedrich Jacob Merck, in a deal valued at 10.6 billion euros.
Altana AG, controlled by the billionaire Quandt family, also agreed last week to sell its drug unit to Danish pharmaceuticals company Nycomed Holding AS for 4.5 billion euros.
Family shareholders are seeking consolidation as drugmakers grapple with the rising cost of developing new medicines and increasing competition from generics. Schwarz's shares had gained 41 percent in the year ended Sept. 22 amid speculation it could become a target as consolidation sweeps the German market.
NO RECIPROCITY: Taipei has called for cross-strait group travel to resume fully, but Beijing is only allowing people from its Fujian Province to travel to Matsu, the MAC said The Mainland Affairs Council (MAC) yesterday criticized an announcement by the Chinese Ministry of Culture and Tourism that it would lift a travel ban to Taiwan only for residents of China’s Fujian Province, saying that the policy does not meet the principles of reciprocity and openness. Chinese Deputy Minister of Culture and Tourism Rao Quan (饒權) yesterday morning told a delegation of Chinese Nationalist Party (KMT) lawmakers in a meeting in Beijing that the ministry would first allow Fujian residents to visit Lienchiang County (Matsu), adding that they would be able to travel to Taiwan proper directly once express ferry
FAST RELEASE: The council lauded the developer for completing model testing in only four days and releasing a commercial version for use by academia and industry The National Science and Technology Council (NSTC) yesterday released the latest artificial intelligence (AI) language model in traditional Chinese embedded with Taiwanese cultural values. The council launched the Trustworthy AI Dialogue Engine (TAIDE) program in April last year to develop and train traditional Chinese-language models based on LLaMA, the open-source AI language model released by Meta. The program aims to tackle the information bias that is often present in international large-scale language models and take Taiwanese culture and values into consideration, it said. Llama 3-TAIDE-LX-8B-Chat-Alpha1, released yesterday, is the latest large language model in traditional Chinese. It was trained based on Meta’s Llama-3-8B
STUMPED: KMT and TPP lawmakers approved a resolution to suspend the rate hike, which the government said was unavoidable in view of rising global energy costs The Ministry of Economic Affairs yesterday said it has a mandate to raise electricity prices as planned after the legislature passed a non-binding resolution along partisan lines to freeze rates. Chinese Nationalist Party (KMT) lawmakers proposed the resolution to suspend the price hike, which passed by a 59-50 vote. The Taiwan People’s Party (TPP) voted with the KMT. Legislative Speaker Han Kuo-yu (韓國瑜) of the KMT said the resolution is a mandate for the “immediate suspension of electricity price hikes” and for the Executive Yuan to review its energy policy and propose supplementary measures. A government-organized electricity price evaluation board in March
NOVEL METHODS: The PLA has adopted new approaches and recently conducted three combat readiness drills at night which included aircraft and ships, an official said Taiwan is monitoring China’s People’s Liberation Army (PLA) exercises for changes in their size or pattern as the nation prepares for president-elect William Lai’s (賴清德) inauguration on May 20, National Security Bureau (NSB) Director-General Tsai Ming-yen (蔡明彥) said yesterday. Tsai made the comment at a meeting of the Legislative Yuan’s Foreign Affairs and National Defense Committee, in response to Democratic Progressive Party (DPP) Legislator Wang Ting-yu’s (王定宇) questions. China continues to employ a carrot-and-stick approach, in which it applies pressure with “gray zone” tactics, while attempting to entice Taiwanese with perks, Tsai said. These actions aim to help Beijing look like it has